NVIDIA Corporation vs. Starling Oncology, Inc. Common Stock
NVIDIA Corporation (NVDA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| NVDA | STLN | |
|---|---|---|
| Market Cap | $5.42 trillion | $665.51 million |
| Revenue (TTM) | $302.97 billion | — |
| Net Income (TTM) | $192.88 billion | — |
NVDA leads on 1 of 1 size & scale factors.
Valuation
| NVDA | STLN | |
|---|---|---|
| P/E Ratio | 28.45 | — |
| Price / Book | 23.68 | — |
| Price / Sales | 17.90 | — |
NVDA and STLN split the valuation factors evenly.
Profitability
| NVDA | STLN | |
|---|---|---|
| Net Margin | 63.66% | — |
| Return on Equity | 84.23% | — |
NVDA and STLN split the profitability factors evenly.
Dividend
| NVDA | STLN | |
|---|---|---|
| Dividend Yield | 0.44% | — |
| Payout Ratio | 12.64 | — |
NVDA and STLN split the dividend factors evenly.
Risk & Sentiment
| NVDA | STLN | |
|---|---|---|
| Short Interest | 0.07% | 6.89% |
NVDA leads on 1 of 1 risk & sentiment factors.
Dig deeper: NVDA overview, NVDA financials, STLN overview, STLN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.